4//SEC Filing
Borgman Anne Elizabeth 4
Accession 0001415889-25-006655
CIK 0001382101other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:57 PM ET
Size
14.3 KB
Accession
0001415889-25-006655
Insider Transaction Report
Form 4
Borgman Anne Elizabeth
CHIEF MEDICAL OFFICER
Transactions
- Tax Payment
Common Stock
2025-03-01$1.59/sh−4,621$7,347→ 53,098 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-02-28−37,500→ 75,000 totalExp: 2027-02-28→ Common Stock (37,500 underlying) - Exercise/Conversion
Common Stock
2025-02-28+37,500→ 61,874 total - Exercise/Conversion
Common Stock
2025-03-01+11,250→ 57,719 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-03-01−11,250→ 33,750 totalExp: 2028-03-01→ Common Stock (11,250 underlying) - Tax Payment
Common Stock
2025-02-28$1.59/sh−15,405$24,494→ 46,469 total
Footnotes (4)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
- [F2]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F3]The RSU award vests as to 1/4th of the total award annually on the last calendar day of February, beginning on February 29, 2024, subject to continued service through each vesting date.
- [F4]The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date.
Documents
Issuer
SUTRO BIOPHARMA, INC.
CIK 0001382101
Entity typeother
Related Parties
1- filerCIK 0001886388
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:57 PM ET
- Size
- 14.3 KB